EMD vs MVP

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

EMD

EMYRIAL FPO [EMD]

51MEDIUM

MVP

MEDICALDEV FPO [MVP]

51MEDIUM

Score Breakdown

EMD MVP
Technical
55
72
Catalyst
52
50
Sentiment
50
50
Fundamental
65
88
Momentum
76
41
Risk Gate
45
50

Key Metrics

EMD Metric MVP
$35.5MMarket Cap$44.5M
994KAvg Volume (20d)102K
N/AShort InterestN/A
$0.07852-Week High$0.765
$0.02152-Week Low$0.380
+18.9%Daily Change+2.6%
$0.044Entry Price$0.395
-58.6%ROE-0.8%
-198.5%Profit Margin-1.1%

Active Signals

EMD Signals

●On a tear — up 10.0% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (11 quarters)
●Strong revenue growth (+136%)
●Small-cap ($20-100M)
●Deeply negative margins (-199%)
●Not enough chatter to gauge sentiment — defaulting to neutral
●Sentiment is mixed — no strong consensus either way

MVP Signals

●RSI drifting toward oversold territory — worth watching
●MACD just crossed bullish — momentum is shifting to the upside
●Volume surging at 2.1x normal while price climbs — real buying conviction behind this move
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-01-29
●Low P/S ratio (1.1x)

Ask Scout AI to compare EMD and MVP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
EMD Full Analysis → MVP Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).